Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation
Top Cited Papers
- 6 June 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (22) , 2612-2617
- https://doi.org/10.1161/01.cir.101.22.2612
Abstract
Background —The blockade of angiotensin II (Ang II) formation has protective effects on cardiovascular tissue; however, the role of Ang II in atrial electrical remodeling is unknown. The purpose of this study was to investigate the effects of candesartan and captopril on atrial electrical remodeling. Methods and Results —In 24 dogs, the atrial effective refractory period (AERP) was measured before, during, and after rapid atrial pacing. Rapid atrial pacing at 800 bpm was maintained for 180 minutes. The infusion of saline (n=8), candesartan (n=5), captopril (n=6), or Ang II (n=5) was initiated 30 minutes before rapid pacing and continued throughout the study. In the saline group, AERP was significantly shortened during rapid atrial pacing (from 149±11 to 132±16 ms, P P =NS). Although rate adaptation of the AERP was lost in the saline group, this phenomenon was preserved in the candesartan and captopril groups. Conclusions —The inhibition of endogenous Ang II prevented AERP shortening during rapid atrial pacing. These results indicate for the first time that Ang II may be involved in the mechanism of atrial electrical remodeling and that the blockade of Ang II may lead to the better therapeutic management of human atrial fibrillation.Keywords
This publication has 12 references indexed in Scilit:
- Effects of 17β‐Estradiol on Tachycardia‐Induced Changes of Atrial Refractoriness and Cisapride‐Induced Ventricular ArrhythmiaJournal of Cardiovascular Electrophysiology, 1999
- The impact of adjusting for post-test referral bias on apparent sensitivity and specificity of SPECT myocardial perfusion imaging in men and womenJournal of the American College of Cardiology, 1998
- Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart FailureJournal of Molecular and Cellular Cardiology, 1997
- Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs.Pacing and Clinical Electrophysiology, 1997
- Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injuryAmerican Heart Journal, 1994
- Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells.Journal of Biological Chemistry, 1994
- Effects of Verapamil on Electrophysiological Properties in Paroxysmal Atrial FibrillationPacing and Clinical Electrophysiology, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Angiotensin II Receptors in Normal and Failing Human Hearts*Journal of Clinical Endocrinology & Metabolism, 1989
- Effect of enalapril on ventricular arrhythmias in congestive heart failureThe American Journal of Cardiology, 1985